Phase 1 clinical and pharmacokinetics evaluation of oral CI-1033 in patients with refractory cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/15897585

Clin. Cancer Res. 2005 May 15 11 10 3846-53

Download in:

View as

Triples

General Info

PMID
15897585